Tony Singh
Psychiatry · Detroit, MINPI 1467075515
Payments from drug & device makers
Across 116 payments — averaging $27.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$390
- Neurocrine Biosciences, Inc.$361
- Alkermes, Inc.$360
- Lundbeck LLC$330
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$253
- Otsuka America Pharmaceutical, Inc.$231
- plus $1K from 13 others
What the payments were for
- Food & beverage$3,135100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 10 | $390 |
| Neurocrine Biosciences, Inc. | 11 | $361 |
| Alkermes, Inc. | 9 | $360 |
| Lundbeck LLC | 12 | $330 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $253 |
| Otsuka America Pharmaceutical, Inc. | 13 | $231 |
| Teva Pharmaceuticals USA, Inc. | 5 | $227 |
| AbbVie | 11 | $222 |
| TMS Neurohealth Centers Inc. | 1 | $142 |
| Vanda Pharmaceuticals Inc. | 5 | $124 |
| Noven Therapeutics, LLC | 4 | $86 |
| Orexo US, Inc. | 5 | $84 |
| Johnson & Johnson | 4 | $71 |
| Corium, LLC | 3 | $61 |
| Supernus Pharmaceuticals, Inc. | 3 | $59 |
| E.r. Squibb & Sons, L.L.C. | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Indivior Inc. | 1 | $23 |
| Tris Pharma Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,135 in reported general payments places this provider in the 85th percentile of 1,166 psychiatry providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 28 | $2,154 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 23 | $478 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 21 | $476 |
| Bupropion XlBupropion Hcl | 19 | $343 |
| Mirtazapine | 24 | $306 |
| Buspirone Hcl | 22 | $288 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 13 | $262 |
| Quetiapine Fumarate | 24 | $238 |
| Alprazolam | 41 | $230 |
| Trazodone Hcl | 17 | $199 |
| Lorazepam | 37 | $183 |
| Escitalopram Oxalate | 12 | $137 |
| Clonidine Hcl | 12 | $115 |
| Sertraline Hcl | 39 | $107 |
| Clonazepam | 16 | $63 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Detroit
- Andreas SidiropoulasDetroit$2.8M
- Arash JavanbakhtDetroit$102K
- Matcheri KeshavanDetroit$48K
- Gerald WinderDetroit$30K
- John HeadDetroit$28K
- David HarrisDetroit$11K
- Joel YoungRochester Hills$1.9M
- Welton WashingtonYpsilanti$1.4M
- Rajaprabhakaran RajarethinamAnn Arbor$1.2M
- Eric AchtyesGrand Rapids$705K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.